Literature DB >> 605457

Strategy in drug research. Synthesis and study of the progestational and ovulation inhibitory activity of a series of 11beta-substituted-17alpha-ethynyl-4-estren-17beta-ols.

A J Broek, A I Broess, M J Heuvel, H P de Jongh, J Leemhuis, K H Schönemann, J Smits, J de Visser, N P van Vliet, F J Zeelen.   

Abstract

Using the strategy based on the Hansch method which analyses effects of substituents on biological activity in terms of their hydrophobic, electronic and steric effects we selectively synthesised a series of 11beta-substituted-17alpha-ethynyl-4-estren-17beta-ols that combine ease of synthesis with good discrimination between these factors aiming at finding the compounds with optimum biological activity in that series. The compounds were tested quantitatively in the Clauberg test (rabbit) and the ovulation inhibition test (rat). The differences in biological activity could reasonably be correlated with two steric effects introduced by the 11beta-substituent. These were a change in the overall shape of the 11beta-substituent and the angular methyl group, and direct steric hindrance of the steroid-receptor protein binding. Some exceptions were found possibly due to metabolic conversion of these compounds to the corresponding 11beta-substituted-17alpha-ethynyl-1,3,5(10)-estra-triene-3,17beta-diols.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 605457     DOI: 10.1016/0039-128x(77)90095-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  1 in total

1.  Org 4333, a potent, irreversibly binding estrogen agonist.

Authors:  A J van den Broek; J Leemhuis; M S de Winter; F J Zeelen
Journal:  Pharm Weekbl Sci       Date:  1983-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.